L-NAME enhances microcirculatory congestion and cardiomyocyte apoptosis during myocardial ischemia-reperfusion in rats

Shock
Peitan LiuCarl E Hock

Abstract

Besides necrosis, apoptosis is the other major mode of cardiomyocyte loss in ischemic cardiovascular disease. In the present study, we examined the hypothesis that nitric oxide (NO) protects myocardial function by improving myocardial microcirculation and attenuating cardiomyocyte apoptosis in a rat model of myocardial ischemia/reperfusion (MI/R). The left main coronary artery of anesthetized male rats was ligated for 40 min, followed by 4 h reperfusion. Four groups of animals were studied: sham operated control + saline; sham operated control + N(W)-nitro-L-arginine methyl ester (L-NAME); MI/R + saline; MI/R + L-NAME (10 mg/kg, iv, 10 min prior to reperfusion). Results show that MI/R caused a decrease in mean arterial blood pressure (MABP), cardiac index (CI), and stroke volume index (SVI). Inhibition of NO synthesis by L-NAME attenuated plasma NO levels, but increased MABP and SVR in sham control rats and rats subjected to MI/R, and further depressed left ventricular function in rats subjected to MI/R as indicated by decreased CI and SVI. Furthermore, administration of L-NAME to rats subjected to MI/R enhanced cardiomyocyte apoptosis as indicated by a significant increase in DNA fragmentation compared to rats with MI/R alone....Continue Reading

References

Jun 1, 1991·The Journal of Clinical Investigation·H A LehrK Messmer
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D S Bredt, S H Snyder
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M W RadomskiS Moncada
Aug 15, 1991·Biochemical and Biophysical Research Communications·R E Klabunde, R C Ritger
Jan 1, 1988·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·M D MengerK Messmer
Jan 1, 1994·The American Journal of Physiology·H S SilvermanM D Stern
Aug 1, 1996·Experimental Cell Research·W ChengP Anversa
Nov 1, 1996·Circulation Research·H Fliss, D Gattinger
Jan 21, 1997·Circulation·A SarasteL M Voipio-Pulkki
Apr 17, 1997·The New England Journal of Medicine·G OlivettiP Anversa
Jun 20, 1998·Circulation Research·A Haunstetter, S Izumo
Dec 22, 1999·The American Journal of Physiology·P G Lloyd, C D Hardin

❮ Previous
Next ❯

Citations

Jun 19, 2003·The Journal of Trauma·Paul E PepeJane G Wigginton
Sep 16, 2008·Shock·Nathan M NovotnyDaniel R Meldrum
Oct 16, 2008·Clinical and Experimental Hypertension : CHE·Engin SahnaOktay Burma
May 4, 2011·Microscopy Research and Technique·Alma RusM Luisa Del Moral
Aug 12, 2004·Free Radical Biology & Medicine·Stephan BaldusThomas Münzel
Oct 2, 2012·International Journal of Cardiology·Charalampos N PierrakosJohn N Nanas
Oct 12, 2011·The Journal of International Medical Research·Y HouW Guo
Dec 13, 2005·American Journal of Physiology. Cell Physiology·Christian PottWilhelm Bloch
Aug 20, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Tamer I M RagabAl Shimaa Gamal Shalaby

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.